Value of non-reimbursed drug sales in Poland 2019-2023
In 2023, the value of non-reimbursed drug sales in Poland amounted to over 13.4 billion zloty, increasing by 14.3 percent compared to the previous year.
* For commercial use only
Basic Account
Starter Account
The statistic on this page is a Premium Statistic and is included in this account.
Professional Account
1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.
Overview
Manufacturing
Trade
Sales
Products & prices
OTC market
R&D and Clinical trials
Pharmacies
Drugstores
Companies
* For commercial use only
Basic Account
Starter Account
The statistic on this page is a Premium Statistic and is included in this account.
Professional Account
1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.